The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 23 October 2024, approved a license for the medicine donanemab (Kisunla) for use in the early stages of Alzheimer’s ...

The MHRA has approved serplulimab, the UK’s first anti-PD-1 antibody for extensive-stage small cell lung cancer, improving survival options for adults. News & Perspective Tools & Reference CME/CE.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya, Janssen-Cilag Limited) for use in adults with Crohn’s disease and ulcerative colitis (UC). The ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved guselkumab (Tremfya) for the treatment of Crohn’s disease and ulcerative colitis (UC). Already used for plaque psoriasis and ...

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss Rinri Therapeutics Ltd. Tue, Jul 1, 2025, 3:00 AM 3 min read ...

The MHRA advises that women taking GLP-1 medicines—such as Mounjaro, Ozempic, Wegovy, Saxenda, and Victoza—should use effective contraception while on these medications and for a certain ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the prostate cancer imaging agent trofolastat (RoTecPSMA). The regulator’s decision makes trofolastat the first ...